HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Taras Afonyushkin Selected Research

Macular Degeneration (Age-Related Maculopathy)

11/2013Retinal pigment epithelium cells produce VEGF in response to oxidized phospholipids through mechanisms involving ATF4 and protein kinase CK2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Taras Afonyushkin Research Topics

Disease

6Inflammation (Inflammations)
01/2021 - 03/2008
3Atherosclerotic Plaque (Atheroma)
01/2021 - 07/2008
3Pathologic Neovascularization
11/2013 - 07/2008
2Thrombosis (Thrombus)
11/2021 - 09/2007
2Atherosclerosis
01/2021 - 11/2011
1Abdominal Aortic Aneurysm
01/2022
1Sepsis (Septicemia)
01/2021
1Lung Injury
07/2017
1Acute Lung Injury
07/2017
1Pneumonia (Pneumonitis)
07/2015
1Acute Monocytic Leukemia (Acute Monoblastic Leukemia)
02/2015
1ST Elevation Myocardial Infarction
02/2015
1Arthrogryposis renal dysfunction cholestasis syndrome
02/2015
1Macular Degeneration (Age-Related Maculopathy)
11/2013
1Pathologic Processes
11/2013
1Eye Diseases (Eye Disease)
11/2013
1Dyslipidemias (Dyslipidemia)
11/2011
1Type 2 Diabetes Mellitus (MODY)
11/2011
1Metabolic Syndrome (Dysmetabolic Syndrome X)
11/2011
1Cardiovascular Diseases (Cardiovascular Disease)
03/2011
1Coronary Disease (Coronary Heart Disease)
09/2007
1Neointima
09/2007
1Neoplasms (Cancer)
10/2006

Drug/Important Bio-Agent (IBA)

5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2013 - 10/2006
4Phospholipids (Phosphatides)FDA LinkGeneric
07/2017 - 12/2010
3LipopolysaccharidesIBA
07/2017 - 12/2010
2AntibodiesIBA
11/2021 - 02/2015
2Immunoglobulin M (IgM)IBA
11/2021 - 02/2015
2CytokinesIBA
03/2011 - 03/2008
2Oncostatin MIBA
03/2011 - 03/2008
1Lipoproteins (Lipoprotein)IBA
01/2022
1Heparitin Sulfate (Heparan Sulfate)IBA
01/2021
1C-Reactive ProteinIBA
01/2021
1CoagulantsIBA
01/2021
1Tumor Necrosis Factor Ligand Superfamily Member 13IBA
01/2021
1LDL Lipoproteins (beta Lipoproteins)IBA
01/2021
1Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA
01/2021
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2017
1lipoxin A4IBA
07/2017
1oxidized- L- alpha- 1- palmitoyl- 2- arachidonoyl- sn- glycero- 3- phosphorylcholineIBA
07/2017
1EndotoxinsIBA
07/2015
1EpitopesIBA
02/2015
1oxidized low density lipoproteinIBA
02/2015
1Monoclonal AntibodiesIBA
02/2015
1Interleukin-8 (Interleukin 8)IBA
02/2015
1LipidsIBA
11/2013
1Biological ProductsIBA
11/2011
1LigandsIBA
03/2011
1Glycoproteins (Glycoprotein)IBA
03/2011
12- phenyl- 5,5- dimethyltetrahydro- 1,4- oxazineIBA
03/2011
1Phosphatidylcholines (Phosphatidylcholine)IBA
12/2010
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
12/2010
1Fatty Acids (Saturated Fatty Acids)IBA
12/2010
1Plasminogen Activator Inhibitor 1IBA
09/2007

Therapy/Procedure

1Intravenous Injections
11/2021
1Artificial Respiration (Mechanical Ventilation)
07/2017